Cargando…
Effect of dipeptidyl peptidase-4 inhibitors inhibitor on cognitive dysfunction in diabetes: A protocol for systematic review and meta analysis
INTRODUCTION: There is a risk of cognitive impairment in diabetic patients. Some studies have shown that dipeptidyl peptidase-4 inhibitors (DPP-4) inhibitors can play a protective role in controlling blood glucose and blocking the DPP-4 to attach antibody glucagon-like peptide -1 degradation and pro...
Autores principales: | Liu, Shiyu, Wang, Xian, Deng, Huan, Xia, Yuguo, Yang, Xiaomei, Chen, Qiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402785/ https://www.ncbi.nlm.nih.gov/pubmed/32756077 http://dx.doi.org/10.1097/MD.0000000000020707 |
Ejemplares similares
-
Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis
por: Park, Se Hee, et al.
Publicado: (2016) -
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes in Taiwan: A Population-Based Cohort Study
por: Lai, Yun-Ju, et al.
Publicado: (2015) -
Real-world comparison of mono and dual combination therapies of metformin, sulfonylurea, and dipeptidyl peptidase-4 inhibitors using a common data model: A retrospective observational study
por: Lee, Kyung Ae, et al.
Publicado: (2022) -
Cardiovascular risk factors in children and adolescents with subclinical hypothyroidism: A protocol for meta-analysis and systematic review
por: DENG, Huan, et al.
Publicado: (2020) -
Therapies for diabetic gastroparesis: A protocol for a systematic review and network meta-analysis
por: Wang, Shengju, et al.
Publicado: (2020)